Sernova (TSE:SVA) Reaches New 52-Week Low – Should You Sell?

Sernova Corp. (TSE:SVAGet Free Report) shares reached a new 52-week low during mid-day trading on Monday . The stock traded as low as C$0.15 and last traded at C$0.16, with a volume of 4850 shares traded. The stock had previously closed at C$0.15.

Sernova Stock Performance

The company has a quick ratio of 18.11, a current ratio of 0.32 and a debt-to-equity ratio of -4.40. The company has a market cap of C$52.16 million, a price-to-earnings ratio of -1.50 and a beta of 1.35. The stock has a 50 day simple moving average of C$0.19 and a 200 day simple moving average of C$0.22.

Sernova Company Profile

(Get Free Report)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.

Featured Stories

Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.